| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970349 | The Journal of Heart and Lung Transplantation | 2013 | 6 Pages |
Abstract
PH exists in 26% of end-stage CF patients and has no effect on survival on the waiting list for LTx or after LTx. Echocardiography might be used as the first tool to rule out PH, showing a NPV of 88%.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gerdien MD, Maarten J. MD, PhD, Johanna M. MD, PhD, Mochamed A. MD, Sabrin BSc, Harold W. MD, PhD, Ed A. MD, PhD,